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Abstract
The enzyme of the pentose phosphate pathway (PPP) ribulose-5-phosphate-epimerase
(RPE) is encoded by two genes present in the genome of Trypanosoma cruzi CL Brener
clone: TcRPE1 and TcRPE2. Despite high sequence similarity at the amino acid residue
level, the recombinant isoenzymes show a strikingly different kinetics. Whereas TcRPE2 fol-
lows a typical michaelian behavior, TcRPE1 shows a complex kinetic pattern, displaying a
biphasic curve, suggesting the coexistence of -at least- two kinetically different molecular
forms. Regarding the subcellular localization in epimastigotes, whereas TcRPE1 is a cyto-
solic enzyme, TcRPE2 is localized in glycosomes. To our knowledge, TcRPE2 is the first
PPP isoenzyme that is exclusively localized in glycosomes. Over-expression of TcRPE1,
but not of TcRPE2, significantly reduces the parasite doubling time in vitro, as compared
with wild type epimastigotes. Both TcRPEs represent single domain proteins exhibiting the
classical α/β TIM-barrel fold, as expected for enzymes with this activity. With regard to the
architecture of the active site, all the important amino acid residues for catalysis -with the
exception of M58- are also present in both TcRPEs models. The superimposition of the
binding pocket of both isoenzyme models shows that they adopt essentially identical posi-
tions in the active site with a residue specific RMSD < 2Å, with the sole exception of S12,
which displays a large deviation (residue specific RMSD: 11.07 Å). Studies on the quater-
nary arrangement of these isoenzymes reveal that both are present in a mixture of various
oligomeric species made up of an even number of molecules, probably pointing to the dimer
as their minimal functional unit. This multiplicity of oligomeric species has not been reported
for any of the other RPEs studied so far and it might bear implications for the regulation of
TcRPEs activity, although further investigation will be necessary to unravel the physiological
significance of these structural findings.
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Introduction
The pentose phosphate pathway (PPP) is a metabolic route that starts with glucose-6-phos-
phate, the first glycolytic intermediate. It consists of two branches, the oxidative branch leading
from glucose 6-phosphate to ribulose-5-phosphate (Ru5P), with the reduction of two mole-
cules of NADP+, and the non-oxidative or sugar interconversion branch, which ultimately,
when functioning as a cycle, leads back to glycolytic intermediates. The PPP usually plays two
major roles, namely the reduction of NADP+ to NADPH, a coenzyme necessary for biosyn-
thetic reactions and for the protection of cells against oxidative stress imposed by reactive oxy-
gen species (ROS), as well as the production of ribose-5-phosphate to be used in nucleic acid
synthesis [1].
Ribulose-5-phosphate epimerase (RPE), which catalyses the reversible conversion of Ru5P
to xylulose-5-phosphate (Xu5P), is an enzyme of the non-oxidative branch of the PPP. RPEs
are broadly distributed in the three kingdoms of life, including most eukaryotic organisms,
fungi and bacteria [2–7]. Little is known about RPEs kinetic properties, but RPE is generally
considered a metalloenzyme in several of the studied organisms and has been shown to use
divalent cations as cofactors or activators [8–11]. As a metalloenzyme, RPE in E.coli is thought
to be one of the principal targets of oxidative stress generated by H2O2 [12,13]. RPEs belong to
the ribulose phosphate binding superfamily, sharing a common (α/β) 8-strand barrel fold and
a conserved phosphate binding motif located at the end of the seventh and eighth β-strands in
most of the members of this family [11]. As for its quaternary structure, RPEs are oligomers
made up of an even number of subunits in most of the organisms studied [3,7–11,14–17].
Trypanosoma cruzi, the parasitic protozoan that causes the American Trypanosomiasis
(Chagas disease) maintains a functional PPP [18]. The seven enzymes of the pathway are pres-
ent in the four major developmental stages of the parasite: the intracellular amastigote and the
bloodstream trypomastigote in the mammalian host, and the epimastigote and metacyclic try-
pomastigote, in the insect vector [19]. Subcellular localization experiments suggested that the
PPP enzymes display a predominant cytosolic component, although in all cases they also seem
to show a minor particulate localization [19].
In several protozoan parasites, enzymes belonging to the oxidative branch of the PPP have
been extensively studied [20–27], but information is scarce on most of the enzymes of the
non-oxidative branch, with the exception of ribose-5-phosphate isomerase from T. cruzi
[28,29], Leishmania donovani [30–33] and T. brucei [34]; and transketolase from Leishmania
mexicana and T.brucei [35–37]. In the present work, we report research on the kinetic proper-
ties of the recombinant TcRPE isoenzymes from T. cruzi, as well as a molecular modeling
study that highlights important functional features of their tertiary structure, and evidence on
their quaternary arrangement obtained by light scattering. Through several different tech-
niques, we were also able to analyze the subcellular localization of the native and recombinant
(over-expressed) TcRPEs in the epimastigote developmental stage.
Materials and methods
Parasites growth
Epimastigotes of the T. cruzi CL Brener clone were grown in axenic medium, harvested and
washed as previously described [38]. Cell-free extracts from epimastigotes were obtained by
three cycles of freezing and thawing, and then suspension was performed in buffer 1 (50 mM
Tris–HCl buffer, pH 7.6, containing 1 mM EDTA and 0.25 M sucrose) in the presence of 0.5
mM tosyl-lysyl-chloromethyl ketone (TLCK). Then the cell-free extracts were treated by soni-
cation in a Branson 450 Sonifier, by three continuous pulses (30-s each) at 60% of maximal
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power. The suspensions were centrifuged at 20,000 x g for 10 min, and the supernatants were
used for the determination of enzymatic activity and preparation of Western blots.
Cloning of TcRPE1 and TcRPE2
The TcRPE1 ORF (Accession code: EU075265.1) of 735 bp and TcRPE2 ORF (Accession code:
EU075266.1) of 744 bp, were amplified by PCR from genomic DNA from T. cruzi CL Brener
clone epimastigotes. Primers were designed according to the sequence data obtained from
GenBank™ database. NdeI and XhoI sites were included to facilitate the directional cloning
into the expression vector. The sequences of the primers were as follows: sense primer
TcRPE1FW: 5'-CATATGTTTGATCACCAGGACCG-3’ and sense primer TcRPE2FW:5'-
CATATGCGCAGCTTTGATCATCAG-3' (start bold, NdeI underlined); antisense primer
TcRPE1RV: 5'-CTCGAGTTTTGGGGTGGAGACTTCTTAC-3' and antisense primer
TcRPE2RV: CTCGAGAAGGTGGGATTTCAAGTGGTGG-3' (XhoI underlined). PCR condi-
tions were as follows: initial denaturation (300 s at 95˚C), 30 cycles of denaturation (30 s at
95˚C), annealing (30 s at 58˚C), elongation (60 s at 68˚C) and a final extension step (90 s at
68˚C). The PCR products were isolated from a 1% agarose gel, purified by the QIAquick PCR
purification kit protocol (Qiagen), and cloned into a pGEM1-T Easy vector (Promega).
Sequencing of the products was performed using the sequencing service provided by MACRO-
GEN (South Korea).
Construction of vector pET-22b(+)-TcRPE1 / TcRPE2, expression, and
purification of recombinant TcRPEs
The TcRPE1 and TcRPE2 genes were excised as NdeI/XhoI fragments from the pGEM1-T
Easy vector, gel purified and subcloned into the NdeI and XhoI sites of the pET-22b(+) expres-
sion vector (Novagen). The resulting constructs presenting a poly-His tag at the C-terminus
were transferred to E. coli BL21 codon Plus (DE3) cells. Transformations with pET-22b
(+)-TcRPE1 and pET-22b(+)-TcRPE2 were performed according to procedures described in
the instruction manual. For expression, a single colony was grown overnight at 37˚C in LB
medium containing 50 μg ml−1 kanamycin and 10 μg ml−1 chloramphenicol. Then, cells were
diluted 1:25 in LB medium [39] containing antibiotics as described above, and grown at 37˚C.
When an optical density of 0.6 at 600 nm was reached, isopropyl-β-D-thiogalactopyranoside
(IPTG) was added to a final concentration of 0.5 mM to induce protein expression. Then,
growth was continued at 18˚C overnight with shaking at 250 rev min−1. Cells were harvested
by centrifugation at 3,000 x g for 10 min at 4˚C and resuspended in lysis buffer containing: 50
mM Tris-HCl, pH 7.5, 500 mM NaCl, 0.1% Triton X-100, 2 mM PMSF, and lysozyme at a
final concentration of 1 mg ml−1. DNA was digested by treatment with DNase I (0.1 mg ml−1
final concentration). The cell-free extract was obtained by centrifugation at 20,000 x g for 25
min at 4˚C.
The recombinant enzymes were purified in one step using Ni2+ resin (GE Healthcare) pre-
equilibrated in 50 mM Tris-HCl (pH 7.6) containing 500 mM NaCl. The column was washed
sequentially with 50 column volumes (CV) of the equilibration buffer and 50 CV of the same
buffer added with 50 mM imidazole. TcRPE1 and TcRPE2 were eluted with 2 CV of the equi-
librium buffer added with 300 mM imidazole and 500 μl fractions were collected. All purifica-
tion procedures were performed at 4˚C and the elution profile was monitored by enzymatic
activity. Purity of the recombinant TcRPEs was analyzed by SDS-PAGE followed by Coomas-
sie Blue staining. The eluted fractions were then pooled and desalted by following the PD-10
desalting column protocol (GE Healthcare), using equilibrium buffer as desalting buffer.
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Cloning, expression and purification of T.cruzi transketolase
Since production of the commercial transketolase (TKT) that we used in the beginning as a
coupled enzyme for the RPE assay was discontinued, we decided to produce the enzyme from
T.cruzi. The TcTKT ORF (Accession code: EU077555.1) of 2019 bp, was amplified by PCR
from genomic DNA from T. cruzi CL Brener clone epimastigotes. Primers were designed
according to the sequence data obtained from GenBank™ database. NheI and XhoI sites were
included to facilitate the directional cloning into the expression vector. The sequences of the
primers were as follows: sense primer TcTKTFW: 5'-CGTACGATGAATAACAGTAAA-3'
(start bold, NheI underlined) and TcTKTRV: 5'-CTCGAGTCACAGATGCACACG-3' (XhoI
underlined). PCR conditions were as follows: initial denaturation (300 s at 95˚C), 30 cycles of
denaturation (30 s at 95˚C), annealing (60 s at 58˚C), elongation (150 s at 68˚C) and a final
extension step (150 s at 68˚C). The PCR products were isolated from a 1% agarose gel, purified
by the QIAquick PCR purification kit protocol (Qiagen), and cloned into a pGEM1-T Easy
vector (Promega). Sequencing of the products was performed by using TcTKTFW, TcTKTRV
and the internal primers: TcTKTFW5: 5'-ACGCGCTTGGTGCTG-3',TcTKTRV3: 5'-
CTCATTGGTGGATCTTCGGA-3' and TcTKTRV4: 5'- GCTACGCGCTTGGTGCTG-3'by
the automated sequencing service provided by MACROGEN (South Korea). The TcTKT gene
was excised as NheI/XhoI fragments from the pGEM1-T Easy vector, gel purified and sub-
cloned into the NheI and XhoI sites of the pET-28a(+) expression vector (Novagen). Then, we
followed the same protocol described to express and purify the recombinant TcRPE1 and 2.
TcTKT active enzyme was purified to homogeneity and stored in glycerol 30% at -80˚C for its
use as a coupled enzyme for the determination of RPE activity.
Fractionation by differential centrifugation
Epimastigotes of the CL Brener clone were disrupted in a mortar using silicon carbide, in a
ratio of 2 g per g of cells, wet weight. The cell paste was suspended in buffer 1 (see above) and
the suspension was centrifuged for 3 min at 100 x g to remove the abrasive powder. The total
homogenate (H) was submitted to fractionation by differential centrifugation [19] and three
fractions were obtained, namely large granules (LG), small granules (SG) and the final super-
natant (S). The resultant SG fraction was used to perform a sucrose linear density gradient cen-
trifugation (see below).
Sucrose linear density gradient centrifugation
Linear and continuous gradients from 0.5 to 2.0 M sucrose in 50 mM Tris-HCl pH 7.6, 1mM
EDTA, were prepared in polyallomer tubes of 16 mm x 67 mm (10.75 ml capacity) by the suc-
cessive addition of layers of sucrose solutions of decreasing density, and the system was left to
equilibrate overnight. Then, the SG fraction (0.25 ml) -obtained by fractionation by differential
centrifugation—was softly homogenized to eliminate any association among particles, and
loaded over the gradient surface. The volume of the tube was completed with 50 mM Tris-
HCl, pH 7.6, 1mM EDTA, and then the tube was heat sealed. Immediately, the tube was placed
in a NVT 65 rotor and centrifuged at 300,000 x g for 3 h. In the end, 23 fractions (0.5 ml each)
were collected by suction, using an automatic collector. Fraction density was determined with
an Abbe refractometer. All the operations were performed between 0 and 4˚C. The activities of
RPE and marker enzymes were determined in reaction mixtures containing 0.2% Triton X-
100 and were represented in frequency histograms, as the total activity of a given fraction rela-
tive to the sum of total activities of all the fractions, as a function of the fraction number
ordered by increasing density.
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Enzyme assays
All enzyme assays were performed at 30˚C in a Beckman DU600 spectrophotometer. RPE
activity was assayed by a coupled enzyme method, as previously described [35] except that
TcRPE1 and TcRPE2 were assayed at pH 7.25 and 7.5, respectively. A concentration of 0.02–2
mM or 0.1–10 mM D-ribulose-5-phosphate was assayed for recombinant TcRPE1 or TcRPE2,
respectively. The TcTKT used as coupled enzyme, was assayed as described in [35]. The other
coupled enzymes were purchased from Sigma Aldrich (St. Louis, MO). The values of the
kinetic parameters KM and kcat for TcRPE2 were obtained after non-linear regression of veloci-
ties in the substrate curves by the Gauss-Newton method, using the Solver application from
Microsoft Office Excel. The data of four independent experiments performed with different
batches of TcRPE2, were fitted using the Michaelis-Menten equation. In a similar fashion, the
data of four independent experiments performed with different batches of TcRPE1, were plot-
ted to determine the complex kinetic pattern shown by this enzyme. Hence, we decided not to
apply any mathematical treatment to these data. The glycosomal marker hexokinase was
assayed as described in [35]. The mitochondrial marker isocitrate dehydrogenase was assayed
in a reaction mixture containing 2 mM MnCl2, 0.5 mM NADP and 2.5 mM isocitrate in 25
mM triethanolamine-HCl buffer (pH 7.5). The reaction was monitored by reading the increase
in the absorbance at 340 nm. The Golgi apparatus marker acid phosphatase was assayed at pH
5.4 in a reaction mixture containing 150 mM citrate, 200 mM pentanediol, 12.5 mM α-
naphthyl phosphate and 75 mM Fast Red TR. The reaction was monitored by reading the
increase in the absorbance at 405 nm. The protein concentration was determined by the Brad-
ford method [40] using bovine serum albumin (BSA) as standard.
Western blot analysis
Proteins from total cell lysates were resolved by SDS-PAGE in 10% polyacrylamide gels, and
transferred by electroblotting to nitrocellulose membranes (Hybond ECL, Amersham Biosci-
ences). Blots were probed for 1 h with monoclonal rat anti-HA (hemagglutinin) antibodies 1/
500 (Roche), with monoclonal mouse anti-α-tubulin antibodies 1/1,000 (Sigma) or with poly-
clonal rabbit anti-GDH (glutamate dehydrogenase) antibodies 1/1,000 (GeneTex). The mem-
branes were then washed and incubated for 1 h with goat anti-rat or goat anti-mouse Alexa
Fluor1 790 1/25,000, or with goat anti-rabbit Alexa Fluor1 680 1/25,000 (Jackson Immuno
Research). Bound conjugate was detected using an Odyssey clx infrared imaging system. Alter-
natively, after incubation with rat anti-HA primary antibodies, membranes were washed and
probed for 1 h with anti-rat horseradish peroxidase conjugate 1/10,000 (Sigma). Bound conju-
gate was detected by SuperSignal1West Pico Chemiluminescent Substrate (Pierce) in con-
junction with X-ray film exposure (AGFA GP-BU New Medical).
Molecular mass determination
The apparent subunit molecular mass of recombinant proteins TcRPE1 and TcRPE2 (Gen-
Bank Accession codes ABW88687.1 and ABW88688.1, respectively) was estimated by SDS–
PAGE, as described by Weber and Osborn [41]. As a first approach, the native recombinant
TcRPE1 and TcRPE2 molecular mass was determined by gel filtration in a Superdex 75 HR
10/30 column (GE Healthcare Amersham Biosciences) with a gel bed of 24 ml. Tris–HCl (50
mM), pH 7.6, containing 500 mM NaCl was used as eluent. Column calibration was performed
using as molecular mass standards: cytochrome c (12.4 kDa), myoglobin (17 kDa), α-chymo-
trypsinogen A (25.7 kDa), and bovine serum albumin (66 kDa). Blue Dextran (2000 kDa) was
used as a marker of the exclusion volume. Protein samples were prepared in the same elution
buffer and centrifuged (20,000 x g at 4˚C for 5 min) before injection. Samples and standards
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(200μl) were resolved at a flow rate of 0.5 ml min−1. Similarly, for size exclusion chromatogra-
phy—light scattering experiments (SEC-FPLC-LS), elution profiles of a Superose 12 column
(GE Healthcare Amersham Biosciences) equilibrated at room temperature with 50 mM Tris-
HCl buffer, pH 7.6, containing 500 mM NaCl, were recorded following the UV absorption at
280 nm (Jasco UV2075 plus), the enzymatic activity and the multi-angle static light scattering
(MASLS) and dynamic light scattering (DLS) signals from in-line modules (Wyatt Technol-
ogy). Protein samples were prepared in the same elution buffer and centrifuged (20,000 x g at
4˚C for 5 min) before injection. Data processing was carried out with the ASTRA software
(Wyatt). The samples (100 μl) and the standards were resolved at a flow rate of 0.4 ml min−1.
Homology modeling
The primary sequences of TcRPE1 and TcRPE2 (GenBank Accession codes ABW88687.1 and
ABW88688.1, respectively) were obtained from the NCBI protein database and were analyzed
using PSI-PRED [42] for the prediction of secondary structure. A Pfam [43] search yielded
conserved domains. SCOP [44] analysis was performed to detect domains based on similarity
with experimental structures. Local alignments were built using the Basic Local Alignment
Search Tool for proteins (BLASTP) [45] accessible at the NCBI-BLAST (http://www.ncbi.nlm.
nih.gov/BLAST). Homologous entries were obtained from the RCSB Protein Data Bank (PDB)
[46]. At first, template selection criteria were based on three different aspects: (i) extent of
identity with the target, (ii) coverage of the target and (iii) crystallographic resolution of the
template. This resulted in a short list of 10 possible templates. Then, to choose the best tem-
plates, we considered the evolutionary closeness of the targets to the templates. Finally, the
putative RPE from Plasmodium falciparum (PDB ID: 1TQX) -displaying 48% and 38%
sequence identity with TcRPE1 and TcRPE2, respectively- and the putative RPE from Toxo-
plasma gondii (PDB ID: 4NU7) -displaying 50% and 47% sequence identity with TcRPE1 and
TcRPE2, respectively- were the templates of choice for the modeling of the monomer of
TcRPE1 and TcRPE2. In this analysis we also included as a template the biochemically vali-
dated human RPE (PDB ID: 3OVQ) that displays 52% and 47% sequence identity with
TcRPE1 and TcRPE2, respectively. The BLAST alignment was further refined by manual cura-
tion, and the final sequence alignment file was used as input to Modeller 9.14 [47]. Homology
modeling of TcRPEs was performed by running Modeller from a Python terminal. One hun-
dred models for each TcRPE based on each of the three templates (simple homology model)
were built. The best model for each set was chosen, according to their DOPE and PDF scores.
The best models were evaluated through DOPE profiles construction and different sets of
parameters calculated by on-line servers. Finally, a refinement process based in energy mini-
mization of the whole molecule was performed, using the 3DRefine server [48], and the result-
ing refined models were compared with the starting models to assess their quality
improvement. For the refined models of TcRPEs, a specific refinement process for loops was
assayed. Neither procedure resulted in significant model improvement. The evaluation of the
final models was performed through the analysis of different stereochemical parameters tested
by the automatic servers Rampage [49], ProQ [50], ERRAT [51], and QMEAN [52]. Finally,
the comparison of the results of the evaluation and validation of the three best final models for
each TcRPE was the basis for choosing only one model for each isoenzyme.
Cloning and over-expression of HATcRPE1, TcRPE1HA, HATcRPE2
and HATcRPE2SHLxAAA in CL Brener clone epimastigotes
Despite many attempts, we were unable to obtain polyclonal antibodies that would allow us to
unambiguously discriminate between wild type TcRPEs isoenzymes. Therefore, to assess their
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subcellular localization we had no choice but to work with the over-expression of tagged
TcRPE1 and TcRPE2.
With the aim of generating a HA-tagged construct of TcRPE1 and TcRPE2 for parasite
over-expression, the TcRPE1 and TcRPE2 ORFS were amplified by PCR from the pGEM1-T
Easy constructs generated (see above). Primers were designed according to the sequence data
obtained from GenBank™ database. MluI and BamHI sites were included to facilitate the direc-
tional cloning into the expression vector. The sequences of the primers were as follows: sense
primer HATcRPE1FW:5'- ACGCGTATGTATCCGTATGATGTGCCGGATTATGCGTTTGAT
CACCAGGACCGTGG-3', HATcRPE2FW: 5'-ACGCGTATGTATCCGTATGATGTGCCGGAT
TATGCGCGCAGCTTTGATCATCAGGAC-3' (start bold, MluI underlined and HA tag in ital-
ics), TcRPE1HAFW: 5'-ACGCGTATGTTTGATCACCAGGACCG-3'; reverse primer HATcR
PE1RV: 5'-GGATCCTTATTTTGGGGTGAGAGACTTC-3', HATcRPE2RV: 5'-GGATCC
CTAAAGGTGGGATTTCAAGTGG-3', TcRPE1HARV: 5'-GGATCCTTACGCATAATCCGG
CACATCATACGGATATTTTGGGGTGAGAGACTTCTTTAC-3'and HATcRPE2SHLxAAARV:
5'-GGATCCCTAATGCTGCTGCTTCAAGTGG-3' (BamHI underlined). PCR conditions were
as follows: initial denaturation (300 s at 95˚C), 25 cycles of denaturation (30 s at 95˚C), anneal-
ing (30 s at 58˚C), elongation (60 s at 68˚C) and a final extension step (90 s at 68˚C). The PCR
products were isolated from a 1% agarose gel, purified by the QIAquick PCR purification kit
protocol (Qiagen), and cloned into a pGEM1-T Easy vector (Promega). Sequencing of the
products was performed by the automated sequencing service provided by MACROGEN
(South Korea). The TcRPE1/TcRPE2 HA tagged genes were excised as MluI/BhamHI frag-
ments from the pGEM1-T Easy vector, gel purified, and subcloned into the MluI and BamHI
sites of the pTcINDEX expression vector [53]. Then T. cruzi CL-Brener epimastigotes were
transfected with circular pLEW13 [53] plasmid and recombinant parasites were selected on
300 μg ml-1 G418 (Invivogen). Stably transfected parasites were obtained after eight weeks.
Then, CL Brener [pLEW13] epimastigotes were transfected with circular pTcINDEX-
HATcRPE1, pTcINDEX-TcRPE1HA, pTcINDEX-HATcRPE2 and pTcINDEX-HATcR
PE2SHLxAAA, lacking the DNA cassette that addresses the integration into the non-
transcribed ribosomal RNA spacer region. Stably transfected parasites were obtained after
eleven weeks, and the selection process was carried out on 300 μg ml-1 hygromicin B (Invivo-
gen). To test the capability of the vector to mediate tetracycline-induced expression, an induc-
tion assay was performed with tetracycline at a final concentration of 5 μg ml-1. The antibiotic
was added once to epimastigotes in the early mid-logarithmic growth phase (approximately 2
x 107 parasites ml-1). Parasites were grown at 28C, with shaking. Samples were removed 24, 48,
72, and 96 h later and analyzed by Western blot and fluorescence microscopy. To determine
growth for the wild-type and transfected epimastigotes, growth curves were started at 1.2 x 107
cells ml-1. Four independent experiments were performed and each time the cells were
counted in triplicate daily for 8 days.
Immunofluorescence assay
Along the logarithmic growth phase, epimastigotes from HATcRPE1, TcRPE1HA,
HATcRPE2, HATcRPE2SHLxAAA and pLEW13 lines were collected by centrifugation,
washed twice with phosphates-buffered saline (PBS) and fixed in PBS containing 4% p-formal-
dehyde for 15 min. Parasites were washed twice, resuspended at 2 x107 parasites ml-1 in PBS,
and attached to polylysine coated glass coverslips for 10 min. Then, coverslips were washed
twice with PBS, treated with 25 mM NH4Cl for 10 min, and washed again twice with PBS. For
permeabilization and blocking, coverslips were then incubated with 2% BSA, 2% normal goat
serum and 0.1% saponin in PBS (blocking solution) for 30 min under humidified atmosphere.
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After that treatment, coverslips were incubated with rat monoclonal anti-HA antibodies
(Roche, Basel, Switzerland) and/or mouse polyclonal antibodies against the glycosomal marker
T.cruzi phosphoenolpyruvate carboxykinase (PEPCK) [54], both at a 1/500 dilution, in block-
ing solution for 1 h under humidified atmosphere and then, washed extensively with PBS.
After this procedure, coverslips were incubated with Alexa Fluor 488 conjugated goat anti-
mouse secondary antibodies (Invitrogen) and/or Rhodamine Red X Goat anti-rat (Pierce) (1/
1,000 diluted in blocking solution) for 1 h in a humidified atmosphere and then washed exten-
sively with PBS. Finally, coverslips were stained and mounted with 4,6-diamidino-2-phenylin-
dole (DAPI) (LifeTechnologies) 1/1,000 diluted in FluorSave (Merck Millipore). Subcellular
localization studies were performed using a Nikon Eclipse E600 fluorescence microscope
attached to a Sport RT Slider digital camera (model 2.3.1, Diagnostic Instruments, Sterling
Heights, MI, USA). Confocal studies were performed with a confocal laser microscope Olym-
pus FV1000 attached to an inverted microscope Olympus IX81 (Melville, NY, USA). Confocal
images were acquired in sequential mode with the FluoView (version 3.3, Olympus, Melville,
NY, USA). Images were processed in Adobe Photoshop (version 8.0.1; Adobe Systems, San
Jose, CA, USA) and pseudo-coloring of images and fluorescence profiles analysis was carried
out using the ImageJ software (version 1.43u).
Statistical analysis
All the assays shown were performed in duplicate or triplicate, and at least three indepen-
dent experiments were performed. Data are presented as the mean ± SEM or SD as indi-
cated in each particular case. Statistical analysis of the data was carried out using unpaired
two-tailed Student’s t test on GraphPad Prism 5 software. The significance of the differences
between experimental groups follows the convention: P < 0.05, P < 0.005 and
P < 0.0001.
Results
The genome of the CL Brener clone of T.cruzi encodes two RPE
isoenzymes
Two genes encoding ribulose-5-phosphate epimerase from T.cruzi CL Brener clone were iden-
tified: TcRPE1 (GenBank Accession code: EU075265.1) and TcRPE2 (GenBank Accession
code: EU075266.1). The two isoenzymes of RPE are 54% identical at the amino acid residue
level (Fig 1) and one of them (TcRPE2) predicts a PTS1 glycosomal targeting signal (SHL) at
the C-terminus. In addition, while in silico predictions -using the ScanProsite tool [55] accessi-
ble at the ExPASy: Bioinformatic Resource Portal site (https://www.expasy.org)- yield two dif-
ferent ribulose 5-phosphate 3’-epimerase family signatures (named Ru5PE Signature 1 and 2)
in TcRPE1, TcRPE2 presents only one (Ru5PE Signature 2). It is important to notice that these
signatures do not correspond to independent substrate binding motifs; both of them contain
residues which are part of the active site, and most of these residues are present in both isoen-
zymes, despite the lack of a complete Signature 1 in TcRPE2 (see the section on “Homology
modeling of TcRPE1 and TcRPE2”).
Since T.cruzi CL Brener strain (TcVI) is a hybrid [56] and it presents several duplicated
genes accounting for the existence of isoforms, it is important to emphasize the presence of
RPE isoforms in other non-hybrid T.cruzi strains. Furthermore, the presence of RPE isoforms
is not only observed for non-hybrid T.cruzi strains, but it is also a widespread feature among
the different T. cruzi Discrete Typing Units (DTUs TcI-TcVI) [57]. T.cruzi CL Brener Esmer-
aldo-like (TcII) presents two RPE isoforms -TryTrip Gene IDs: TcCLB.510257.30 and
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TcCLB.507009.30-, T.cruzi CL Brener Non-Esmeraldo-like (TcIII) also presents two RPE iso-
forms: TryTrip Gene IDs: TcCLB.509213.70 and TcCLB510667.140. The same occurs with
T.cruzi Dm28c (TcI): TryTrip Gene IDs: TCDM_06074 and TCDM_00120; and with T.
cruzi marinkellei [58] strain B7 (Bat Restricted subspecies): TryTrip Gene IDs:
Tc_MARK_8636 and Tc_MARK_4409. This feature is also observed for other protozoan
parasites, such as T. brucei and Leishmania spp (see below). The TcRPE1 and TcRPE2 amino
acid sequences (GenBank Accession codes ABW88687.1 and ABW88688.1, respectively)
were compared with those for the corresponding enzymes from other protozoan parasites,
E. coli, and humans (S1 and S2 Figs). The highest identity: 71.3% for TcRPE1 and 77.7% for
TcRPE2 was observed with the T. brucei putative RPEs (XP823426.1 and CAQ55499.1,
respectively), followed by those from Leishmania major Friedlin: XP001685917.1 is 55.7%
identical to TcRPE1 and XP003722762.1 is 55.9% identical to TcRPE2. A considerable iden-
tity level occurs for the RPEs from Toxoplasma gondii (4NU7, 50% for TCRPE1 and 47% for
TcRPE2), human (3OVQ, 52% for TcRPE1 and 47% for TcRPE2), and Plasmodium falcipa-
rum (1TQX, 48% for TcRPE1 and 38% for TcRPE2). Finally, a greater divergence was
observed when both RPEs were compared with that from E.coli (3CT7, 34 and 33% identity
for TcRPE1 and TcRPE2, respectively).
Cloning, expression and purification of RPE1 and RPE2 from T.cruzi CL
Brener clone
Both TcRPEs were cloned in the bacterial expression plasmid pET-22b(+) and expressed as
recombinant C-terminal (His)6-tagged proteins in E.coli BL21 codon Plus (DE3) cells (S3A
Fig). The cell free extracts containing the recombinant (His)6-tagged proteins were applied to
a Ni2+ Resin (Invitrogen) for immobilized metal ion affinity chromatography (IMAC) purifi-
cation (S3B and S3C Fig). Purity of the recombinant RPEs was analyzed by SDS-PAGE fol-
lowed by Coomassie Blue staining. For both isoenzymes a substantial amount of the protein
was expressed as a soluble, active enzyme that could be purified to homogeneity. A striking dif-
ference in specific activity between TcRPE1 and TcRPE2—almost 80-100-fold- was observed.
Specific activity of the purified recombinant proteins was 52.4 μmol min-1mg-1 for TcRPE1
and 0.69 μmol min-1mg-1 for TcRPE2.
Fig 1. Comparision of amino acid sequences of the RPEs from the CL Brener clone of T.cruzi. Conservation has been indicated by
different tones of grey according to the Boxshade convention (darker grey means more similar residues). At the consensus line, identical
residues are represented in uppercase letter and similar residues in lowercase. The PTS glycosomal targeting signal of TcRPE2 is underlined in
red and the ribulose 5-phosphate 3’-epimerase family signatures—Ru5PE Signature 1 and Ru5PE Signature 2- are marked with black horizontal
lines over and under the letters, respectively.
doi:10.1371/journal.pone.0172405.g001
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Optimal pH and determination of kinetic parameters
Due to the high specific activity of TcRPE1 we had to use the enzyme highly diluted, but we
found that this caused a progressive decay of the enzyme activity if the same diluted sample
was used for all determinations. TcRPE1 lost about 40–50% of its initial activity 3 h after dilu-
tion. The presence of the substrate Ru5P at a final concentration of 1 mM or the addition of
bovine serum albumin (1 to 2 mg ml-1) did not prevent this decay (S4 Fig). For this reason, we
had to employ this enzyme diluted just before the start of each assay.
The optimal pH for the reaction catalyzed by the purified recombinant TcRPEs (Fig 2A)
was determined as described in Materials and Methods. Maximal enzymatic activity was
observed at pH 7.25 for TcRPE1 and at pH 7.5 for TcRPE2. We show only the results obtained
with acetate, Bis-Tris, Tris-HCl buffer (Fig 2B), since it shows the broadest range of buffer
capacity. We also tested Tris-HCl and triethanolamine-HCl at the same concentration. Since
in triethanolamine-HCl both enzymes exhibit the same pH maxima and their highest stability,
this buffer was chosen for all the ensuing activity assays aimed at determining the kinetic
parameters.
Surprisingly, both isoenzymes differ markedly in regard to their kinetic behavior (Fig 2C).
TcRPE1 showed a very complex kinetic pattern to increasing concentrations of Ru5P, display-
ing a biphasic curve, suggesting the coexistence of -at least- two kinetically different molecular
forms. The linearity of the reaction with time (initial velocity) in all zones of the curves was
checked, thus discarding the possibility of an experimental artifact. When the experiment was
repeated several times by using different batches of the recombinant TcRPE1, the general pat-
tern was consistently observed, but with a shift in the transition zone between both phases,
which might be explained by different proportions of -at least- two kinetically different oligo-
meric species (see next Section) comprising each batch of recombinant enzyme. Although
efforts to find a mathematical expression to calculate the kinetic parameters corresponding to
the two phases of the curves were done, reproducible results could not be obtained, and there-
fore kinetic constants for TcRPE1 are not presented.
In contrast, TcRPE2 showed a typical hyperbolic response to increasing concentrations of
Ru5P. After non-linear regression, the values of the kinetic parameters for this isoenzyme were
determined at pH 7.5, by fitting TcRPE2 data from four independent experiments to the
Michaelis-Menten equation, as described in Materials and Methods. We measured a KM value
of 2.21 ± 0.23 mM, a kcat value of 0.32 ± 0.02 s-1, and a kcat/ KM of 0.16 ± 0.02 s-1 mM-1. The
KM value obtained for TcRPE2 was similar to that obtained for the recombinant cobalt metal-
loform RPE from E.coli, with a KM value of 2.40 ± 0.40 mM [12].
Although we cannot compare the kinetic constants for both isoenzymes, inspection of the
graphs in Fig 2C shows that TcRPE1 has a much higher specific activity than TcRPE2, and sug-
gests that at least the kinetic component detected at the lower substrate concentrations must
have also an affinity for Ru5P considerably higher than that for TcRPE2.
To test if the TcRPEs were metalloenzymes, various divalent metals were tested for their
ability to activate these enzymes in vitro. None of the eight cations assayed (Ca2+, Co2+, Cu2+,
Fe2+, Mn2+, Mg2+, Ni2+, Zn2+) at a concentration of 1 mM was able to activate TcRPE1 or
TcRPE2 above background levels (S5 Fig). In addition, purified TcRPE1 was pre-incubated for
1 h in the presence of different chelating agents (5 to 10 mM EDTA, 5 to 10 mM EGTA or 1
mM o-phenanthroline). Even after many independent replicates of the assay, inconsistent
results were obtained. Since the method we used for RPE activity determination involves a
magnesium-dependent TKT as a coupled enzyme, we had to work with TcRPE1 highly diluted
after its preincubation with chelating agents, in order to prevent any inhibition of the coupled
enzyme. Given that TcRPE2 shows low specific activity, we were not able to test the effect of
The ribulose 5-phosphate epimerase isoenzymes from Trypanosoma cruzi
PLOS ONE | DOI:10.1371/journal.pone.0172405 February 16, 2017 10 / 27
chelating agents on the activity of this isoenzyme. Although these results suggest that recombi-
nant TcRPE1 does not bear an exposed divalent metal cation essential for enzymatic activity,
the aforementioned experimental limitations prevented us to reach a definite answer to this
issue.
Finally, the treatment with 1 to 5 mM DTT or with 10 mM cysteine, and the treatment with
5 to 10 μM H2O2 (S6 Fig) brought about no effect on the activity of either enzyme, suggesting
that TcRPEs do not bear thiol groups essential for their activity. This finding is in good agree-
ment with the absence of any conserved cysteine residue in the multiple sequence alignment
analysis (S1, S2 and S8 Figs).
Fig 2. (A) Recombinant TcRPE1 and TcRPE2 preparations used for enzymatic assays. SDS-PAGE analysis followed by Coomassie Blue staining to
assess the purity of the recombinant proteins TcRPE1 and TcRPE2. (B) Relative RPE activity as a function of pH for TcRPE1 and TcRPE2. Acetate,
Bis-Tris, Tris-HCl buffer (50 mM each) was used over the complete pH range. Maximal activity was also observed at the same pH values if Tris-HCl or
triethanolamine-HCl buffers were used instead. (C) Plot of RPE specific activity as a function of the concentration of the substrate Ru5P for TcRPE1
and TcRPE2. While TcRPE2 presents a typical hyperbolic response, TcRPE1 shows a very complex kinetic behavior to increasing concentrations of Ru5P.
One of four independent experiments is shown as an example for each isoenzyme. The Hanes-Woolf plot is shown as an inset at the lower right of each
panel. The experimental points shown are the mean of two determinations.
doi:10.1371/journal.pone.0172405.g002
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Oligomeric composition of the recombinant TcRPE1 and TcRPE2 from
T.cruzi
The subunit size of the recombinant TcRPE1 and TcRPE2 enzymes -as estimated by SDS
PAGE- was 27 and 27.7 kDa, respectively (S7 Fig), values that fall in good agreement with
those predicted by the theoretical molecular weight computing tool of the Expasy web server
[59].
To determine the native molecular weight for both recombinant TcRPEs, we initially car-
ried out size exclusion chromatography (SEC) experiments. Given that more than one active
peak eluted for each TcRPEs, and as the assignment of each peak to a defined molecular weight
was unclear, we decided to run a SEC experiment using a Superose 12 column, equipped with
an on-line light scattering detector (SEC-FPLC-LS) (see Materials and Methods). This
approach is much more reliable and accurate for the determination of molecular masses than
SEC alone [60,61], because it is able to provide independent and absolute (i.e. calibration-free)
values of molecular mass. In addition, measuring the absorbance at 280 nm alongside each
chromatographic run allowed us to yield a profile where for each eluted peak an associated
molecular mass cloud could be estimated from the scattering signal. Surprisingly, through its
application we found that both TcRPEs present multiple oligomeric species. This trait is
unique among all the RPEs studied so far [1–9,14], that present only one oligomeric species
apart from the monomer. LS reveals the presence of species in solution with molecular masses
of 23, 53, 119, 160 and 216 kDa for TcRPE1 (Fig 3A) (corresponding to monomer, dimer, tet-
ramer, hexamer and octamer, respectively) and molecular masses of 25, 62 and 109 kDa for
TcRPE2 (corresponding to monomer, dimer and tetramer, respectively) (Fig 3B). Remarkably,
all the oligomeric forms found for each TcRPE result from associations of an even number of
molecules. This new finding could be explained if dimers act as the minimal assembly units
giving rise to the larger oligomeric structures observed. This interpretation is consistent with
previous reports for some RPEs [9,10,14]. The different fractions eluted from the Superose 12
column were collected, and their activity was measured (Fig 3C and 3D). We found activity
associated to each peak fractions showing scattering. However, for both isoenzymes the mono-
mers presented only marginal activity. The TcRPE1 isoenzyme shows maximal enzymatic
activity for the larger oligomeric species (119–160 kDa). By contrast, TcRPE2 does not show
higher activity for the larger oligomers (the maximum occurs for the dimeric form of 61.5
kDa). The TcRPE1 and TcRPE2 isoenzymes not only organize themselves into different sets of
oligomeric species -with TcRPE1 showing a higher proportion of oligomeric species rich in
larger oligomers- but there is also a difference between isoenzymes regarding the distribution
of activity associated to each oligomer. The more complex oligomeric profile and the RPE
activity distribution among the different oligomers observed for TcRPE1 might be linked to
the complex kinetic behavior of this isoform. However, since the different oligomeric species
of TcRPEs might be involved in a dynamic equilibrium mixture that will necessarily be
affected by dilution, unambiguous assignment of specific activity for any of these oligomeric
forms is not straightforward.
Homology modeling of TcRPE1 and TcRPE2
To determine the tertiary structure of each TcRPE isoenzyme, non-automatic homology
modeling was performed using Modeller, with the aid of a Python programming interface, so
as to control each step along the process. In order to look for template candidates, the RCSB
(Protein Data Bank) database was searched. The amino acid sequences extracted were com-
pared (S8 Fig). Basing our decision criterion on different features of the templates -as
described in Materials and Methods- the same 3 templates were chosen for each TcRPE: the
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putative RPE from Plasmodium falciparum (PDB ID: 1TQX), the putative RPE from Toxo-
plasma gondii (PDB ID: 4NU7), and the biochemically validated human RPE (PDB ID:
3OVQ). Three sets of 100 models were built for each TcRPE based on each chosen template.
The best model for each set was selected, evaluated, refined and re-evaluated -as described in
Materials and Methods- and final refined models were compared to choose only one for each
TcRPE (Tables 1 and 2). Results from these comparisons showed that the best models for
TcRPE1 and TcRPE2 are those constructed with 1TQX and 3OVQ templates,respectively.
The structural quality control analysis of the final 3D models chosen for TcRPE1 and
TcRPE2 was carried out using the following servers: ProQ [50], Rampage [49], ERRAT [51],
Q-MEAN [52] and the Verify 3D program [48] installed in Structural Analysis and Verifica-
tion Server tools (SAVES). The Ramachandran plot produced for the refined model of
TcRPE1 by Rampage showed 98.3% residues in favorable regions, 4.5% in allowed regions and
1.7% in disallowed regions. Correspondingly, for the refined model of TcRPE2, 95.5% residues
occur in favorable regions, 4.5% in allowed regions, and no residue was found in disallowed
Fig 3. Each TcRPE displays a complex oligomeric composition. Panels A, C and B, D correspond to TcRPE1 and TcRPE2, respectively.
Absorbance at 280 (thin blue line), molecular mass in kDa estimated by LS (clouds points of different color) and RPE activity (thin red line). Panels E
and F summarize in tabular form the different oligomeric states found for TcRPE1 and TcRPE2, respectively.
doi:10.1371/journal.pone.0172405.g003
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regions (Fig 4A and 4B). This analysis indicates that the backbone dihedral angles psi and phi
in each protein model are reasonably accurate. ERRAT plots indicate overall quality factors of
93.6 and 90.1 (very good quality) for the TcRPE1 and TcRPE2 models, respectively (Fig 4C
and 4D). In addition, the models were also analyzed with the ProQ server, a neural network
based quality predictor, obtaining LG scores of 4.4 for TcRPE1 and 4.6 for TcRPE2. Thus, both
meet the criteria for very good models. Furthermore, for both TcRPE models the quality of the
fit of each amino acid sequence to the environment dictated by the protein fold was evaluated
using Verify3D, obtaining 95.5 and 83% of the residues with an average 3D-1D score > = 0.2
for TcRPE1 and TcRPE2, respectively, indicating good compatibility between the atomic
model (3D) and the target amino acid sequence (1D). In general, the folding energy of proteins
shows negative values, a fact consistent with the stability and native character of the molecules.
We evaluated this energy using the Q-MEAN server, obtaining z-scores of -0.32 for TcRPE1
and -0.69 for TcRPE2. For both models this energy remains negative for all amino acid resi-
dues, indicating a consistently high level of quality. All in all, the analysis of these sets of
parameters let us be confident on the reliability of the models created for TcRPE1 and
TcRPE2. The spatial superimposition between the models for TcRPE1 and TcRPE2 and their
corresponding templates 1TQX and 3OVQ shows that both models bear close similarity to
their templates, with an overall RMSD value of 0.49 Å for TcRPE1 (for 215 paired Cα atoms
Fig 5A) and a RMSD value of 1.01 Å (for TcRPE2 for 220 paired Cα atoms S9 Fig). Given that
this homology modeling exercise yields similar results for each TcRPE, only the results for the
TcRPE1 isoenzyme are shown and further discussed. The overall structure of the TcRPE1
monomer folds into a single α/β domain shaped as a variant of a classical TIM-barrel (Fig 5C).
A central eight-stranded parallel β-sheet makes up the cylindrical core of the barrel. This
nucleus is surrounded by eight α-helices, inserted between consecutive strands and connected
with them by αβ loops. Flexible loops spanning residues G60 to S67 and E168 to P172 are con-
served between the model and the template. It has been reported that they fold over the active
site, and are well positioned to sequester reaction intermediates during catalysis [9]. The active
site of the TcRPE1 template structure (P. falciparum RPE) shows two bound ligands: a zinc
and a sulfate ion, which are embedded in the model structure. Superimposition of the binding
pocket (Fig 5B) shows that the canonic catalytic tetrad (H54, D56, H88, D195) is fully con-
served. According to information available for the template that was used for modeling
TcRPE1, these residues participate in divalent zinc ion coordination at the active site and have
also been reported to do so in other known RPEs [8,9,11]. These divalent ions are putatively
involved in catalysis, stabilizing a 2, 3-enediolate intermediate [8]. In addition, the presence of
amino acid residues that were previously reported as important for substrate docking, such as














1TQX 48 92 98.3 4.5 1.7 93.6 4.4 95.5 -0.32 0.49 (215 paired Cα
atoms)
4NU7 50 91 92.1 5.8 2.1 85.2 3.6 99.6 -1.13 1.67 (216 paired Cα
atoms)
3OVQ 52 89 94.2 3.7 2.1 80.1 3.9 93.4 -0.93 0.78 (208 paired Cα
atoms)
Comparison among the best three molecular models for TcRPE1 built with different templates. The best final model of choice is shaded in yellow.
doi:10.1371/journal.pone.0172405.t001
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G169, G197 and G217, that had been implicated in the constriction of the active site [9]; M58,
M90 and M161, involved in polar cushioning to help stabilize the 2, 3-enediolate intermediate
[11,16]; and S12, associated to a hydrogen bonded network important for the relay of charge
in the enzyme-substrate binary complex [11], are present and well positioned in TcRPE1
model (Fig 5D). With the exception of M58, all the residues mentioned above are also present
in TcRPE2 model. The superimposition of the binding pocket of both TcRPE1 and TcRPE2
models shows that they are also found in essentially identical positions in the active site (resi-
due specific RMSD < 2Å), with the exception of S12 which displays a residue specific RMSD
of 11.07 Å (S10 Fig).
Over-expression and subcellular localization
The intracellular localization of TcRPE1 and TcRPE2 was studied in cultured epimastigotes of
T.cruzi CL Brener clone by immunofluorescence. While TcRPE2 presents a PTS1 glycosomal
targeting signal (SHL) at the C-terminus [62], the TcRPE1 amino acid sequence lacks conspic-
uous organelle targeting signals, suggesting a possible cytoplasmic fate. To reveal the localiza-
tion of these proteins, both TcRPEs were cloned in the tetracycline-inducible expression vector
pTcINDEX [53] and expressed as recombinant HA-tagged proteins in CL Brener pLEW13














1TQX 38 91 94.7 4.1 1.2 82.8 3.9 82.1 -1.02 2.05 (217 paired Cα
atoms)
4NU7 47 88 92.2 4.9 2.9 77.2 3.9 93.3 -1.45 1.24 (216 paired Cα
atoms)
3OVQ 47 87 95.5 4.5 0 90.1 4.6 83 -0.69 1.01 (209 paired Cα
atoms)
Comparison among the best three molecular models for TcRPE2 built with different templates. The final model of choice for is shaded in yellow.
doi:10.1371/journal.pone.0172405.t002
Fig 4. Overall Ramachandran and Errat plots for the refined models of TcRPE1 (A, C) and TcRPE2 (B, D).
doi:10.1371/journal.pone.0172405.g004
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epimastigotes by means of an induction assay with tetracycline. Samples for Western blot and
immunofluorescence analysis were taken 72 h after tetracycline induction. The TcRPE1 isoen-
zyme was HA-tagged at its N (HATcRPE1 line) or C-terminus (TcRPE1HA line), while
TcRPE2 was only HA-tagged at its N-terminus (HATcRPE2 line) to prevent any effect on its
PTS1 glycosomal targeting signal (SHL) at the C-terminus. As expected, episomal over-expres-
sion resulted in production of a ~30 kDa protein for all the lines, in good agreement with the
predicted value for both TcRPEs (taking into account the added 9 amino acid residues from
the HA tag), as detected by Western blot analysis using an anti-HA antibody (Fig 6A). No dif-
ferences on the over-expression were observed when all the transfected lines were compared
by means of a semi-quantification analysis of the Western blot images (Fig 6B). For
Fig 5. (A) Ribbon representation of the superimposition between the model for TcRPE1 (in magenta) and its template 1TQX (in lemon green).
The coordinated zinc ion is shown as a grey sphere and the bound sulfate ion is represented in yellow sticks. (B) Zoom view of the superimposition of the
active site, showing the catalytic tetrad in stick representation. Ru5P is represented in orange sticks. (C) Ribbon depiction of the overall structure of the
TcRPE1 model: the central β-sheet core is shown in yellow, the αβ loops in green, and the α-helices in red. (D) Zoom view on the active site of the model
for TcRPE1, where the catalytic tetrad is shown in blue, and residues involved in substrate docking are shown in grey and red sticks. Ru5P is painted in
purple.
doi:10.1371/journal.pone.0172405.g005
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Fig 6. HATcRPE1 and TcRPE1HA over-expression enhances the growth of T. cruzi CL Brener epimastigotes.
(A) Equal amounts of total cell free extracts from HATcRPE1, TcRPE1HA, and HATcRPE2 CL Brener [pLEW13] lines
after 72h induction with 5 μg/ ml tetracycline were loaded on SDS PAGE followed by Western blot analysis using rat anti-
HA monoclonal antibodies (α-HA) and mouse anti-tubulin antibodies (α-tubulin). (B) The intensity of the HATcRPE1,
TcRPE1HA and HATcRPE2 bands was quantified in three independent experiments and normalized to α-tubulin
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HATcRPE1 and TcRPE1HA lines, there was a considerable leak in the absence of tetracycline,
but -given our goals-, this did not represent an obstacle (S11 Fig). After the heterologous
expression of the different HA tagged constructions was confirmed, we proceeded to investi-
gate the growth of the transfected epimastigotes in vitro. pLEW13 (control), HATcRPE1,
TcRPE1HA and HATcRPE2 parasites were grown in BHT medium and monitored for 8 days
until the stationary phase had been reached (Fig 6C and S12 Fig). The over-expression of
HATcRPE1 and TcRPE1HA did significantly reduce the parasite doubling time in vitro (dou-
bling times of 1.76 ± 0.08 days, p< 0.0001 unpaired t test and 2.14 ± 0.11 days, p< 0.005
unpaired t test, respectively), compared with the pLEW13 control (2.77 ± 0.04 days). In con-
trast, the over-expression of HATcRPE2 (doubling time of 2.68 ± 0.07) did not significantly
modify the parasite doubling time observed under normal conditions (Fig 6D).
Fluorescent microscopy analysis shows that TcRPE1 is mainly localized in the cytosol,
regardless of where the HA tag is placed. Instead, TcRPE2 shows a particulate localization pat-
tern, in agreement with the presence of the PTS1 signal at its C-terminus (Fig 7A). In addition,
fluorescent confocal analysis shows co-localization between TcRPE2 and the glycosomal
marker phosphoenolpyruvate carboxykinase (PEPCK), suggesting that TcRPE2 is indeed a
glycosomal enzyme. Moreover, this co-localization is lost when the same analysis is run with
the HATcRPE2SHLxAAA mutant bearing the substitution of the SHL putative glycosomal tar-
geting signal for AAA, showing that the subcellular localization of TcRPE2 is dependent on its
targeting signal (Fig 7B). The over-expression of HATcRPE2SHLxAAA did significantly
enhance the parasite doubling time in vitro (3.21 ± 0.07 days, p< 0.005 unpaired t test) com-
pared with the pLEW13 control, even when its over-expression was lower than that observed
for HATcRPE2 (S13 Fig). This phenomenon is in agreement with the observations made for T.
brucei [63] where the over-expression in bloodstream trypanosomes of the glycosomal enzyme
PGKC (phosphoglycerate kinase C), lacking the final 5 amino acids which are responsible for
glycosomal targeting, resulted in a toxic effect that causes cell death.
Furthermore, to ascertain the subcellular localization of natural TcRPEs in epimastigotes,
we performed a sucrose linear density gradient centrifugation with the SG fraction obtained
by subcellular fractionation of wild type CL Brener clone parasites (as described in Materials
and Methods). Our results show that TcRPE2 presents an activity peak coincident with that
observed for the activity peak of the glycosomal marker hexokinase (Fig 7C), evidence that
also agrees with the glycosomal localization expected for this enzyme.
Discussion
At variance with all the other PPP enzymes from T.cruzi, TcRPE presents two isoenzymes
sharing 53% identity with each other: TcRPE1 and TcRPE2. In this study, both isoenzymes
were expressed as His-tagged recombinant proteins, which resulted functionally active for the
interconversion of Ru5P into Xu5P. Despite high sequence similarity, TcRPE1 shows a very
different specific activity: 80-100-fold greater than TcRPE2, and a strikingly different kinetic
behavior. Whereas TcRPE2 shows a typical hyperbolic response to increasing concentrations
of Ru5P, TcRPE1 shows a complex kinetic pattern, displaying a biphasic curve, suggesting the
presence of -at least- two different kinetic components. This kinetic pattern is similar to the
intensity. The bar graph represents the mean ± SEM of the relative intensity of the bands. (C) Growth curves of pLEW13
(control), HATcRPE1, TcRPE1HA and HATcRPE2 strains under tetracycline induction. One of four independent
experiments is shown as an example. The semi-log growth is shown as an inset. Black bars represent the SD mesured
by counting cell number daily by triplicate. (D) Doubling times of the HATcRPE1, TcRPE1HA and HATcRPE2 strains
were estimated from four independent experiments. The bar graph represents the mean ± SEM of the doubling time.
doi:10.1371/journal.pone.0172405.g006
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Fig 7. Subcellular localization of the two RPE isoenzymes. (A) Immunofluorescence assay of
epimastigotes from HATcRPE1, TcRPE1HA, and HATcRPE2 CL Brener [pLEW13] lines after 72 h induction
with tetracycline. From left to right: Parasites immunostained with rat anti-HA antibodies, nuclei and
kinetoplasts (DAPI), merge image, and cell bodies visualized by interference contrast (DIC). The bar equals
5 μm. (B) Confocal images showing HATcRPE2, HATcRPE2SHLxAAA and PEPCK co-localization in CL
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one previously reported for the malic enzyme II of T.cruzi [64] and for anthranilate synthetase
from Salmonella typhimurium [65], but it has never been reported for any of the enzymes of
the PPP pathway in T.cruzi, T.brucei, Leishmania or other trypanosomatids. For the TcRPE1
isoenzyme, circumstantial evidence points to the null effect of divalent cations on its activity.
However, a definitive answer to this point will require further analysis. In the case of RPEs
from other sources for which crystallographic structures have been obtained, some of them
present a divalent cation [8–11] at the active site, whereas others do not [14,16].
The tertiary structure for both TcRPEs was studied by a non-automatic homology modeling
procedure that included control checkpoints along the modeling process, ultimately leading to
the generation of very accurate structures. As expected for proteins sharing a high identity
with each other (more than 40% according to established criteria), both TcRPEs constitute sin-
gle domains exhibiting the classical α/β TIM-barrel fold, as shown for other enzymes with RPE
activity. For both isoenzymes there is only one active site per monomer subunit. With regard
to the architecture of the active site, we found that most of the important amino acid residues
for catalysis and substrate binding are present in both isoenzymes, with the sole exception of
M58 that is absent in the TcRPE2 active site. It is noteworthy that the triad of M residues
(M58, M90, and M161) has been reported to participate in the stabilization of the reaction
intermediate [11, 16], and therefore the lack of one of them might affect catalysis. The super-
imposition of the binding pocket of both TcRPE1 and TcRPE2 models shows that catalytically
essential amino acids adopt identical orientations in space (a residue specific RMSD< 2Å for
all of them), with the exception of S12 displaying a residue specific RMSD of 11.07 Å. Interest-
ingly, this residue has been proposed to participate in the relay of charge in the enzyme-sub-
strate binding complex [11]. The subtle differences mentioned above in regard to the
organization of the active site might contribute to explain the striking difference in specific
activity between the two isoenzymes, and the apparently considerably lower affinity of
TcRPE2 for the substrate Ru5P.
An approach to the quaternary arrangement of these enzymes carried out by light scattering
reveals a distinctive feature of TcRPEs. Both isoenzymes present a mixture of various oligo-
meric species made up of an even number of units, probably pointing to the dimer as the mini-
mal entity capable of exerting catalysis. This multiplicity of oligomeric species has not been
reported for any other RPE studied so far [1–9,14]. Suggestively, involvement of these oligo-
mers in a dynamic equilibrium might be linked to the progressive loss of stability observed for
TcRPE1 as the enzyme is diluted. Equilibrium perturbation by dilution of the equilibrium
existing among different TcRPE1 oligomeric species might bring about a change in oligomeric
composition and -consequently- in specific activity. Moreover, this feature might play a role in
explaining the complex kinetic pattern observed for the TcRPE1 isoenzyme. In this scenario,
TcRPE1 shows a maximum of enzymatic activity for large oligomeric species (119–160 kDa)
whereas for TcRPE2 the maximal activity is centered around the dimeric form (61.5 kDa).
Brener [pLEW13] lines after 72 h induction with tetracycline. From left to right: parasites immunostained with
mouse anti-PEPCK polyclonal antibodies, parasites immunostained with rat anti-HA antibodies, cell bodies
visualized by interference contrast (DIC), merge image, and line profiles of fluorescense relative intensity as a
function of position for HATcRPE2 and HATcRPE2SHLxAAA (red line) and PEPCK (green line). The bar
equals 5 μm. (C) Sucrose linear density gradient centrifugation of small granule fraction obtained from intact
wild type epimastigotes of T.cruzi CL Brener clone. Plot of frequency (calculated as described in Materials and
Methods) as a function of the fraction number ordered by increasing density. From left to right and from top to
bottom, the activity of the following enzymes was assayed: TcRPE2; isocitrate dehydrogenase, a
mitochondrial marker; hexokinase, a glycosomal marker, and acid phosphatase, a Golgi apparatus marker.
Equilibrium densities of the fraction exhibiting maximal activity is indicated in each panel and expressed in g
ml-1.
doi:10.1371/journal.pone.0172405.g007
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This fact might help explain why increased complexity in oligomeric composition in the case
of TcRPE1 might find a correlate with increased complexity in the kinetic pattern. Although
further investigation will be necessary to unravel the physiological significance of these find-
ings, this trait differentiates TcRPEs from RPEs from all the other sources studied so far and it
might bear implications for the regulation of TcRPE activity. Different cellular conditions
could promote a change in TcRPEs oligomeric composition, allowing the regulation of these
isoenzymes under different physiological circumstances, in a fashion similar to that reported
for the 6-phosphogluconate dehydrogenase of T.brucei [66], another enzyme of the pentose
phosphate pathway.
Regarding the subcellular compartmentalization of TcRPEs we found that in T. cruzi epi-
mastigotes, whereas TcRPE1 adopts a cytosolic location, TcRPE2 shows a perfect co-localiza-
tion with the glycosomal marker PEPCK, pointing to the effective migration of this protein to
glycosomes, as expected from its PTS1 C-terminal signal. Furthermore, the subcellular locali-
zation of TcRPE2 is absolutely dependent on the presence of its targeting signal, since the
over-expression of a truncated mutant -HATcRPE2SHLxAAA- lacking the putative glycoso-
mal targeting signal, not only remains in the cytosol, but also negatively affects parasite growth,
extending its doubling time in vitro. Collectively, this evidence points to the physiological
importance of TcRPE2 compartmentalization, as has been previously shown for the case of
phosphoglycerate kinase C from T.brucei [63]. On the other hand, the over-expression of
HATcRPE1 and TcRPE1HA shortens the epimastigotes doubling time in vitro, whereas the
over-expression of HATcRPE2 does not significantly alter the parasite growth curve measured
under normal conditions. The positive effect in epimastigotes growth as a consequence of
TcRPE1 over-expression might be attributed to an increased metabolic flux towards the non-
oxidative branch of the PPP generated by TcRPE1 over-expression, enabling a better satisfac-
tion of nucleotide biosynthesis requirements for cell proliferation, through the incremental
production of ribose 5-phosphate.
To the best of our knowledge, TcRPE2 is the first reported PPP isoenzyme that is exclusively
localized in glycosomes in T.cruzi epimastigotes, where most of PPP enzymes share only a
minor glycosomal component [19]. For T.brucei [67,68] and Leishmania spp [35,69,70] only a
partial glycosomal component for some of the PPP enzymes has been previously reported.
Taken together, our findings on the kinetics, structure and localization of both TcRPEs
from T.cruzi CL Brener clone describe striking differences between both isoenzymes. The very
unique features of these enzymes might add a further regulation layer of importance for the
physiology of the parasite, specifically for the physiological role of the PPP in the cytosol and
the glycosome. However, there is, so far as we know, no information about the role of the path-
way in these two locations in T. cruzi. The enzymes of the PPP are encoded in the genomes of
T. cruzi, T. brucei and Leishmania spp, and all of them are expressed in all parasite stages, both
in the mammalian host and in the insect vector, with one notorious exception: RPE and TKT
are not expressed in the bloodstream trypomastigotes of T. brucei. Reference [71] reviews the
information on the PPP enzymes in the three trypanosomatids, and the possibility that some
of them might become targets for chemotherapy. The oxidative branch of the PPP has been
shown to be functional in T. cruzi epimastigotes [19] and in L. mexicana promastigotes [35],
and most probably is also functional in all the other parasite stages, as well as in T. brucei, since
it is essential for the generation of NADPH, required both to protect the parasites against oxi-
dative stress and for biosynthetic processes, and also to provide ribose 5-phosphate for nucleo-
tide synthesis. It is remarkable that, although the non-oxidative branch cannot be operative in
bloodstream trypomastigotes of T. brucei, ribose phosphate isomerase is present, and has been
recently shown, by RNAi experiments, to be required for growth in vitro and for the blood-
stream forms infectivity in mice [34].
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Further studies will be required to assess the functionality of the whole non-oxidative
branch of the PPP in Trypanosomatids. In the case of T. cruzi, the evaluation of the essentiality
of the different enzymes will be difficult to determine, since it lacks the RNAi gene silencing
mechanism, and gene knockout is difficult in this parasite.
Supporting information
S1 Fig. Primary structure analysis of T.cruzi RPE1. The predicted amino acid sequences of
TcRPE1 (ABW88687.1), T.brucei RPE1 (XP823426.1) L.major Friedlin RPE (XP001685917.1),
T.gondii RPE (4NU7), Human RPE (3OVQ), P. falciparum RPE (1TQX) and E.coli RPE
(3CT7) were aligned using the Clustal Omega multiple alignment program. Conservation has
been indicated by different tones of grey according to the Boxshade convention (darker grey
means more similar residues). At the consensus line, identical residues are represented in
uppercase letter and similar residues in lowercase. Amino acid residues involved in catalysis
are annotated with 1. The sequences corresponding to the ribulose-phosphate-3-epimerase
(Ru5PE) family signature 1 and 2 are underlined.
(TIF)
S2 Fig. Primary structure analysis of T.cruzi RPE2. The predicted amino acid sequences of
TcRPE2 (ABW88688.1), T.brucei RPE2 (CAQ55499.1) L.major Friedlin RPE2
(XP003722762.1), T.gondii RPE (4NU7), Human RPE (3OVQ), P.falciparum RPE (1TQX) and
E.coli RPE (3CT7) were aligned using the Clustal Omega multiple align program. Conservation
has been indicated by different tones of grey according to Boxshade convention (darker grey
means more similar residues). At the consensus line, identical residues are represented in
uppercase letter and similar residues in lowercase. Amino acid residues involved in catalysis
are annotated with 1. The sequence corresponding to the Ru5PE family signature 2, is under-
lined.
(TIF)
S3 Fig. Expression and purification of the two RPE isoforms. (A) SDS-PAGE analysis of the
expression of the two RPE isoforms (Coomassie Blue staining). SDS-PAGE analysis to assess
the purity of the recombinant proteins TcRPE1 (B) and TcRPE2 (C), along the different frac-
tions resulting from the IMAC purification (Coomassie Blue staining). The abbreviations Sol
and Insol mean supernatant and pellet, respectively.
(TIF)
S4 Fig. Dilution of TcRPE1 isoform showed a negative effect over the enzyme stability in
time. TcRPE1 was diluted 500-fold in the absence (darker grey) or in the presence (light grey)
of 1 mM Ru5P and it was incubated during 3h at room temperature. Aliquots were taken after
20, 60, 120 and 190 minutes, and activity measurements were performed. One of three inde-
pendent experiments is shown as an example. The black bars represent the mean ± SD
obtained after measure the activity in duplicated for each of the treatments.
(TIF)
S5 Fig. TcRPE1 (A) and TcRPE2 (B) are not activated by the addition of divalent cations.
None of the eight cations assayed (1 mM Ca2+, 1 mM Co2+, 1 mM Cu2+, 1mM Fe2+, 1 mM
Mn2+, 1 mM Mg2+, 1 mM Ni2+, and 1 mM Zn2+) was able to activate recombinant TcRPEs
above background levels. One of three independent experiments is shown as an example. The
black bars represent the mean ± SD obtained after measure the activity in duplicated for each
of the treatments.
(TIF)
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S6 Fig. TcRPE1 (A) and TcRPE2 (B) do not bear thiol groups essential for their activity.
None of the agents assayed (5 mM DTT, 10 mM cysteine or 10 mM H2O2) was able to inhibit
recombinant TcRPEs under background levels. One of three independent experiments is
shown as an example. The black bars represent the mean ± SD obtained after measure the
activity in duplicated for each of the treatments.
(TIF)
S7 Fig. Monomer molecular mass estimated by denaturing gel electrophoresis
(SDS-PAGE). Left panel SDS-PAGE followed by Coomassie Blue staining, showing TcRPE1
and TcRPE2. Differents amounts of the recombinant enzymes were used, namely 3, 1.5, and
0.75 μg for TcRPE1, and 0.85, 1.7, 3.4, and 6.8 μg for TcRPE2. Right panel: plot of the loga-
rithm of molecular mass as a function of relative mobility for several molecular weight markers
and for the TcRPE enzymes.
(TIF)
S8 Fig. Multiple amino acid sequence alignment (MSA) of the TcRPE orthologs deposited
in PDB. Amino acid sequences of Trypanosoma cruzi RPE1 (ABW88687.1), Trypanosoma
cruzi RPE2 (ABW88688.1), Human RPE (3OVQ), Rice RPE (1H1Y), Plasmodium falciparum
RPE (1TQX), Toxoplasma gondii RPE (4NU7), Streptococcus pyogenes RPE (2FLI), Francisella
tularensis RPE (3INP), Synechocystis RPE (1TQJ), potato chloroplast RPE (1RPX), E. coli RPE
(3CT7) and Haemophilus somnus RPE (3CU2) were aligned using the Clustal Omega multiple
alignment program. Conservation has been indicated by different tones of grey according to
the Boxshade convention (darker grey means more similar residues). At the consensus line
identical residues are represented in uppercase letter and similar residues in lowercase. Amino
acid residues directly involved in catalysis are annotated with 1, those involved in substrate
docking with 3, and those belonging to the capping loop with 2.
(TIF)
S9 Fig. Ribbon representation of the superimposition between the model of TcRPE2 (in
blue) and its template 3OVQ (in grey).
(TIF)
S10 Fig. Amino acid residues important for catalysis and substrate docking found in essen-
tially identical positions in the active site of TcRPE1 and TcRPE2 models. Superimposition
of the active sites of TcRPE1 and TcRPE2 models. Important amino acid residues for catalysis
and substrate docking are shown in red sticks for TcRPE1 and in green sticks for TcRPE2.
Ribulose 5-phosphate is shown as yellow sticks. The S12 amino acid residue is not shown to
attain clear visualization of the active site residues.
(TIF)
S11 Fig. Inducible over-expression of the two TcRPE isoforms. Western blot of cell free
extracts from HATcRPE1, TcRPE1HA, and HATcRPE2 CL Brener [pLEW13] lines after 72 h
induction with tetracycline, with rat anti-HA antibodies. Different amounts of induced and
non induced (control) parasites -ranging from 2 to 20 millions- were loaded to attain clear
visualization.
(TIF)
S12 Fig. Growth curves of pLEW13 (control), HATcRPE1, TcRPE1HA and HATcRPE2
strains under tetracycline induction. Parasites were grown in BHT medium and followed for
8 days until the stationary phase was reached. Four independent experiments performed for
each transfected line are shown.
(TIF)
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S13 Fig. Inducible over-expression and growth curves of HATcRPE2SHLxAAA. (A) West-
ern blot of cell free extracts from HATcRPE2, HATcRPE2SHLxAAA lines after 72 h induction
with tetracycline, with rat anti-HA antibodies and rabbit anti-GDH antibodies as loading con-
trol.(B) The intensity of the HATcRPE2 and HATcRPE2SHLxAAA bands was quantified
from three independent experiments and normalized to α-GDH intensity. The bar graph rep-
resents the mean ± SEM of the relative intensity of the bands.(C) Gowth curves of HATcR-
PE2SHLxAAA strain under tetracycline induction. Parasites were grown in BHT medium and
followed for 10 days until the stationary phase was reached. Three independent experiments
were performed, named Curve #1–3. (D) Doubling times of the pLEW13, HATcRPE2 and
HATcRPE2SHLxAAA lines were calculated from three independent experiments. The bar
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